Search This Blog

Monday, November 4, 2019

Karyopharm Therapeutics EPS beats by $0.17, beats on revenue

Karyopharm Therapeutics (NASDAQ:KPTI): Q3 GAAP EPS of -$0.67 beats by $0.17.
Revenue of $13.15M (+5379.2% Y/Y) beats by $11.35M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)